Following a major investigation of the affairs of three German drug wholesaling groups, three former board members of these companies have been arrested on charges of embezzlement of over 10 million Deutschemarks ($6.3 million), according to the Nuernberg Justice Department.
The three men were formerly on the boards of Otto Stumpf AG, F Reichelt AG and Hageda AG. The only one named to date is Rudolf Dittrich, who left Stumpf in May 1993. The current board maintains that Mr Dittrich is largely to blame for the high losses of 56 million marks reported in 1993, through diversions of capital into loss-making channels.
Mr Dittrich has rejected these accusations, and a legal case between him and Stumpf is currently pending.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze